These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 23382988)

  • 21. Association of a single nucleotide polymorphism near the interleukin-28B gene with response to hepatitis C therapy in HIV/hepatitis C virus-coinfected patients.
    Rallón NI; Naggie S; Benito JM; Medrano J; Restrepo C; Goldstein D; Shianna KV; Vispo E; Thompson A; McHutchison J; Soriano V
    AIDS; 2010 May; 24(8):F23-9. PubMed ID: 20389235
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interleukin-28B TT genotype is frequently found in patients with hepatitis C virus cirrhosis but does not influence hepatocarcinogenesis.
    de la Fuente S; Citores MJ; Duca A; Cisneros E; Baños I; Vilches C; Cuervas-Mons V
    Clin Exp Med; 2017 May; 17(2):217-223. PubMed ID: 27083168
    [TBL] [Abstract][Full Text] [Related]  

  • 23. IL28B gene polymorphisms and viral kinetics in HIV/hepatitis C virus-coinfected patients treated with pegylated interferon and ribavirin.
    Rallón NI; Soriano V; Naggie S; Restrepo C; Goldstein D; Vispo E; McHutchison J; Benito JM
    AIDS; 2011 May; 25(8):1025-33. PubMed ID: 21505315
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interleukin-28B single nucleotide polymorphism of donors and recipients can predict viral response to pegylated interferon/ribavirin therapy in patients with recurrent hepatitis C after living donor liver transplantation.
    Kawaoka T; Takahashi S; Takaki S; Hiramatsu A; Waki K; Hiraga N; Miki D; Tsuge M; Imamura M; Kawakami Y; Aikata H; Ochi H; Onoe T; Tashiro H; Ohdan H; Chayama K
    J Gastroenterol Hepatol; 2012 Sep; 27(9):1467-72. PubMed ID: 22432893
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long-term outcome of hepatitis C infection after liver transplantation.
    Gane EJ; Portmann BC; Naoumov NV; Smith HM; Underhill JA; Donaldson PT; Maertens G; Williams R
    N Engl J Med; 1996 Mar; 334(13):815-20. PubMed ID: 8596547
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Combinations of simple baseline variables accurately predict sustained virological response in patients with recurrent hepatitis C after liver transplantation.
    Crespo G; Carrión JA; Coto-Llerena M; Mariño Z; Lens S; Pérez-Del-Pulgar S; García-Retortillo M; Miquel R; Bosch J; Navasa M; Forns X
    J Gastroenterol; 2013 Jun; 48(6):762-9. PubMed ID: 23011083
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association between IL28B gene polymorphisms and plasma HCV-RNA levels in HIV/HCV-co-infected patients.
    Labarga P; Soriano V; Caruz A; Poveda E; Di Lello FA; Hernandez-Quero J; Moreno S; Bernal E; Miró JM; Leal M; Gutierrez F; Portilla J; Pineda JA;
    AIDS; 2011 Mar; 25(6):761-6. PubMed ID: 21378537
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interleukin-28 and hepatitis C virus genotype-4: treatment-induced clearance and liver fibrosis.
    Derbala M; Rizk N; Shebl F; Alkaabi S; Eldweik N; John A; Sharma M; Yaqoob R; Almohanadi M; Butt M; Alejji K
    World J Gastroenterol; 2012 Dec; 18(47):7003-8. PubMed ID: 23323000
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Influence of interleukin-28B single-nucleotide polymorphisms on progression to liver cirrhosis in human immunodeficiency virus-hepatitis C virus-coinfected patients receiving antiretroviral therapy.
    Barreiro P; Pineda JA; Rallón N; Naggie S; Martín-Carbonero L; Neukam K; Rivero A; Benito JM; Caruz A; Vispo E; Camacho A; Medrano J; McHutchison J; Soriano V
    J Infect Dis; 2011 Jun; 203(11):1629-36. PubMed ID: 21592993
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Spontaneous clearance of hepatitis C infection after liver transplantation from IL28B rs12979860 CC donors.
    Chin JL; Nicholas RM; Russell J; Carr M; Connell J; Stewart S; McCormick PA
    Eur J Gastroenterol Hepatol; 2012 Sep; 24(9):1110-2. PubMed ID: 22664940
    [TBL] [Abstract][Full Text] [Related]  

  • 31. IL28B polymorphism and cytomegalovirus predict response to treatment in Egyptian HCV type 4 patients.
    El Awady MK; Bader El Din NG; Tabll A; El Hosary Y; Abdel Aziz AO; El Khayat H; Salama M; Abdelhafez TH
    World J Gastroenterol; 2013 Jan; 19(2):290-8. PubMed ID: 23345953
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Early viral load and recipient interleukin-28B rs12979860 genotype are predictors of the progression of hepatitis C after liver transplantation.
    Graziadei IW; Zoller HM; Schloegl A; Nachbaur K; Pfeiffer KP; Mark W; Mikuz G; Pratschke J; Margreiter R; Vogel W
    Liver Transpl; 2012 Jun; 18(6):671-9. PubMed ID: 22298465
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interferon-lambda4 genetic polymorphism is associated with the therapy response for hepatitis C virus recurrence after a living donor liver transplant.
    Konishi H; Motomura T; Matsumoto Y; Harimoto N; Ikegami T; Yoshizumi T; Soejima Y; Shirabe K; Fukuhara T; Maehara Y
    J Viral Hepat; 2014 Jun; 21(6):397-404. PubMed ID: 24750545
    [TBL] [Abstract][Full Text] [Related]  

  • 34. IL28B gene polymorphism rs12979860, but not rs8099917, contributes to the occurrence of chronic HCV infection in Uruguayan patients.
    Echeverría N; Chiodi D; López P; Sanchez Ciceron A; Angulo J; López-Lastra M; Silvera P; Canavesi A; Bianchi C; Colistro V; Cristina J; Hernandez N; Moreno P
    Virol J; 2018 Mar; 15(1):40. PubMed ID: 29499724
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The impact of IL28B genetic variants on recurrent hepatitis C in liver transplantation: significant lessons from a dual graft case.
    Motomura T; Taketomi A; Fukuhara T; Mano Y; Takeishi K; Toshima T; Harada N; Uchiyama H; Yoshizumi T; Soejima Y; Shirabe K; Matsuura Y; Maehara Y
    Am J Transplant; 2011 Jun; 11(6):1325-9. PubMed ID: 21645259
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Test of IL28B polymorphisms in chronic hepatitis C patients treated with PegIFN and ribavirin depends on HCV genotypes: results from a meta-analysis.
    Jia Z; Ding Y; Tian S; Niu J; Jiang J
    PLoS One; 2012; 7(9):e45698. PubMed ID: 23029188
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hepatitis C virus-specific T-cell response correlates with hepatitis activity and donor IL28B genotype early after liver transplantation.
    Tsuzaki R; Takaki A; Yagi T; Ikeda F; Koike K; Iwasaki Y; Shiraha H; Miyake Y; Sadamori H; Shinoura S; Umeda Y; Yoshida R; Nobuoka D; Utsumi M; Nakayama E; Fujiwara T; Yamamoto K
    Acta Med Okayama; 2014; 68(5):291-302. PubMed ID: 25338486
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Potential role for interleukin-28B genotype in treatment decision-making in recent hepatitis C virus infection.
    Grebely J; Petoumenos K; Hellard M; Matthews GV; Suppiah V; Applegate T; Yeung B; Marks P; Rawlinson W; Lloyd AR; Booth D; Kaldor JM; George J; Dore GJ;
    Hepatology; 2010 Oct; 52(4):1216-24. PubMed ID: 20803561
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Donor IFNL4 Genotype Is Associated with Early Post-Transplant Fibrosis in Recipients with Hepatitis C.
    Aiken T; Garber A; Thomas D; Hamon N; Lopez R; Konjeti R; McCullough A; Zein N; Fung J; Askar M; John BV
    PLoS One; 2016; 11(11):e0166998. PubMed ID: 27875564
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Genetic polymorphism of IL28B in hepatitis C-infected haemophilia patients in Israel.
    Maor Y; Morali G; Bashari D; Pénaranda G; Schapiro JM; Martinowitz U; Halfon P
    Haemophilia; 2013 Jan; 19(1):150-6. PubMed ID: 22913807
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.